BU-BMC Cancer Seminar Series
The Cancer Center sponsors a monthly seminar series that serves to highlight the basic, clinical, and translational cancer research being undertaken at Boston University. The goal of this seminar series is to promote interactions and provide an effective platform for the exchange of ideas and technologies. Beginning in 2016, seminars will incorporate visiting professors from outside of Boston University that are at the forefront of cancer research allowing us to enrich our training environment and enhance communications with the cancer community at large.
The BU-BMC Cancer Seminar Series 2016-2017
Boston University Medical Campus in the Evans Biomedical Research Center (EBRC)
650 Albany Street, 7th Floor, X715
Noon – 1:00 p.m.
Thursday, March 30, 2017
“Metabolic dependencies in prostate cancer: regulation and targeting of lipogenesis”
Massimo Loda, M.D.
Professor, Pathology, Harvard Medical School
Principal Investigator, Pathology, Dana-Farber Cancer Institute
Senior Pathologist, Pathology, Brigham and Women’s Hospital
Thursday, April 27, 2017: The Jerry Brody Lectureship
Honoring Dr. Jerome S. Brody, MD, for his 20+ years of leadership as Pulmonary Center Director
Pasi A. Jänne, M.D., Ph.D.
Director, Lowe Center for Thoracic Oncology
Scientific Director, Belfer Center for Applied Cancer Science
Professor of Medicine, Harvard Medical School
Thursday, May 25, 2017: Dahod Breast Cancer Research Visiting Professor Lecture
Nina A. Bickell, M.D.
Professor, Population Health Science and Policy
Professor, Medicine, General Internal Medicine
Mount Sinai Hospital
Thursday, June 29, 2017
“Engineering in vitro models of tissue functions”
Christopher S. Chen, M.D., Ph.D.
Professor of Biomedical Engineering, Boston University
Wyss Institute for Biologically Inspired Engineering, Harvard University
Thursday, January 26, 2017: The Cooperband Lectureship (In honor of the first BU-BMC Cancer Center Director, Dr. Sidney R. Cooperband) and Dahod Breast Cancer Research Visiting Professor Lecture
“Breast Tumor Evolution”
Kornelia Polyak, M.D., Ph.D.
Professor of Medicine
Department of Medical Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Thursday, December 15, 2016
“PID1, an obesity-relevant gene with novel function(s) in cancer and a yet-unknown molecular mechanism”
Anat Erdreich-Epstein, M.D., Ph.D.
Associate Professor of Pediatrics and Pathology
Keck School of Medicine, University of Southern California and Pediatric Brain Tumor Program
Children’s Center for Cancer and Blood Disease
Children’s Hospital Los Angeles
Monday, October 17, 2016
“Therapeutic targeting of Id2, a transcription factor: a novel approach to brain tumor treatment”
Mark A. Israel, M.D.
Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer
Director, Norris Cotton Cancer Center, an NCI-designated Comprehensive Cancer Center
Professor of Pediatrics and of Genetics
Geisel School of Medicine at Dartmouth
Dartmouth-Hitchcock Medical Center
Thursday, September 29, 2016
“Regional immunotherapy for solid tumors”
Steven C. Katz, M.D.
Associate Professor of Surgery
Director, Complex General Surgical Oncology Fellowship
Director, Office of Therapeutic Development
Roger Williams Medical Center
Thursday, June 30th, 2016
“Translating cancer research at BU-BMC”
Avrum Spira, M.D., M.Sc.
Professor of Medicine, Pathology, and Bioinformatics
Chief, Division of Computational Biomedicine
Director, Boston University-Boston Medical Center Cancer Center